{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:38:14Z","timestamp":1792798694101,"version":"4.5.0"},"reference-count":136,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["MR\/W006804\/1"],"award-info":[{"award-number":["MR\/W006804\/1"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>IgG is the most abundant antibody in the human circulation. It carries a single conserved glycosylation site, Asparagine 297, in its Fc domain. This N-glycan is critical for the ability of the antibody to activate immune cells via binding to, and cross-linking Fc receptors in order to elicit functional responses. First documented in the context of rheumatoid arthritis (RA), the IgG N-glycan may undergo changes that are correlated to host health. We present a narrative in-depth comparison of changes incurred by IgG N-glycans in autoimmune diseases; RA, systemic lupus erythematosus, multiple sclerosis, type I diabetes, primary biliary cholangitis and inflammatory bowel disease (Crohn\u2019s disease and ulcerative colitis). Based on a systematic literature search, we identify common traits and features that are specific for any one autoimmune disease. Our analysis shows that the single most common trend in most of the conditions analyzed here is increased IgG agalactosylation. Changes to the IgG N-glycan typically accompany and often precede disease onset and flare-ups, while they decrease in remission and pregnancy. The correlation of agalactosylated IgG with inflammatory disease is so striking that the agalactosylated IgG N-glycan has long been viewed as inflammatory and even pathogenic. Yet, despite the association with inflammation, any mechanism by which disease-associated IgG N-glycans may mediate their pro-inflammatory nature remains enigmatic.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1933960","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:14:56Z","timestamp":1791198896000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["IgG N-glycosylation in autoimmune diseases"],"prefix":"10.3389","volume":"17","author":[{"given":"Caroline","family":"Pumpe","sequence":"first","affiliation":[{"name":"Centre for Inflammation Research, Institute for Regeneration and Repair, The University of Edinburgh","place":["Edinburgh, Scotland, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Vermeren","sequence":"additional","affiliation":[{"name":"Centre for Inflammation Research, Institute for Regeneration and Repair, The University of Edinburgh","place":["Edinburgh, Scotland, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1304365","article-title":"Impact of structural modifications of IgG antibodies on effector functions","volume":"14","author":"Damelang","year":"2023","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/imr.12350","article-title":"Mouse and human FcR effector functions","volume":"268","author":"Bruhns","year":"2015","journal-title":"Immunol Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1126\/science.1144603","article-title":"Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange","volume":"317","author":"van der Neut Kolfschoten","year":"2007","journal-title":"Science"},{"key":"B5","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41467-025-67105-9","article-title":"Widespread Fab-arm exchange affects all endogenous serum IgG4","volume":"17","author":"Wollenweber","year":"2025","journal-title":"Nat Commun"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-09-179754","article-title":"Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses","volume":"113","author":"Bruhns","year":"2009","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.7.4580","article-title":"Neonatal FcR expression in bone marrow-derived cells functions to protect serum IgG from catabolism","volume":"179","author":"Akilesh","year":"2007","journal-title":"J Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/ncomms1608","article-title":"Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential","volume":"2","author":"Stapleton","year":"2011","journal-title":"Nat Commun"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.2.661","article-title":"Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation","volume":"178","author":"Tao","year":"1993","journal-title":"J Exp Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.1038\/s41467-023-39788-5","article-title":"Complement is activated by elevated IgG3 hexameric platforms and deposits C4b onto distinct antibody domains","volume":"14","author":"Abendstein","year":"2023","journal-title":"Nat Commun"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao4988","article-title":"Structures of C1-IgG1 provide insights into how danger pattern recognition activates complement","volume":"359","author":"Ugurlar","year":"2018","journal-title":"Science"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2406192121","article-title":"Complement activation by IgG subclasses is governed by their ability to oligomerize upon antigen binding","volume":"121","author":"Frischauf","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.5b02366","article-title":"Site-specific protein N- and O-glycosylation analysis by a C18-porous graphitized carbon-liquid chromatography-electrospray ionization mass spectrometry approach using pronase treated glycopeptides","volume":"87","author":"Stavenhagen","year":"2015","journal-title":"Anal Chem"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.m114.047381","article-title":"Hinge-region O-glycosylation of human immunoglobulin G3 (IgG3)","volume":"14","author":"Plomp","year":"2015","journal-title":"Mol Cell Proteomics"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2015.06.015","article-title":"The structural role of antibody N-glycosylation in receptor interactions","volume":"23","author":"Subedi","year":"2015","journal-title":"Structure"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.80.21.6632","article-title":"Biological significance of carbohydrate chains on monoclonal antibodies","volume":"80","author":"Nose","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1200501","article-title":"Impact of immune complex size and glycosylation on IgG binding to human FcgammaRs","volume":"190","author":"Lux","year":"2013","journal-title":"J Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/10.5.477","article-title":"Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics","volume":"10","author":"Raju","year":"2000","journal-title":"Glycobiology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00608","article-title":"The N-glycosylation of mouse immunoglobulin G (IgG)-fragment crystallizable differs between IgG subclasses and strains","volume":"8","author":"de Haan","year":"2017","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-70115-4_8","article-title":"Epigenetic regulation of glycosylation","volume":"1325","author":"Indellicato","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41392-024-01886-1","article-title":"Glycosylation: mechanisms, biological functions and clinical implications","volume":"9","author":"He","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1523968113","article-title":"B-cell-independent sialylation of igG","volume":"113","author":"Jones","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00617","article-title":"Blood-borne ST6GAL1 regulates immunoglobulin production in B cells","volume":"11","author":"Irons","year":"2020","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.3ma0522-731r","article-title":"Divergent Golgi trafficking limits B cell-mediated IgG sialylation","volume":"112","author":"Glendenning","year":"2022","journal-title":"J Leukoc Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2511216122","article-title":"Endothelial cells sialylate IgG within the FcRn-mediated recycling pathway","volume":"122","author":"Glendenning","year":"2025","journal-title":"Proc Natl Acad Sci USA"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.10.035","article-title":"Differences in IgG autoantibody Fab glycosylation across autoimmune diseases","volume":"151","author":"Koers","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2017.09.001","article-title":"Variable domain glycosylation of ACPA-IgG: a missing link in the maturation of the ACPA response","volume":"186","author":"Kempers","year":"2018","journal-title":"Clin Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1039\/c8an02014k","article-title":"Distribution of abnormal IgG glycosylation patterns from rheumatoid arthritis and osteoarthritis patients by MALDI-TOF-MS(n)","volume":"144","author":"Sun","year":"2019","journal-title":"Analyst"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2014.12.002","article-title":"Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: a critical review","volume":"57","author":"Maverakis","year":"2015","journal-title":"J Autoimmun"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(88)91781-3","article-title":"Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity","volume":"1","author":"Parekh","year":"1988","journal-title":"Lancet"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.151.2.1137","article-title":"Detection of glycosylation abnormality in rheumatoid IgG using N-acetylglucosamine-specific Psathyrella velutina lectin","volume":"151","author":"Tsuchiya","year":"1993","journal-title":"J Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199908)42:8<1682::aid-anr17>3.0.co;2-x","article-title":"Sugar printing rheumatic diseases: a potential method for disease differentiation using immunoglobulin G oligosaccharides","volume":"42","author":"Watson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/0896-8411(91)90053-f","article-title":"Abnormalities in the glycosylation of IgG in spouses of patients with rheumatoid arthritis. A family study","volume":"4","author":"Sumar","year":"1991","journal-title":"J Autoimmun"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/ard.50.9.607","article-title":"Reduction in IgG galactose in juvenile and adult onset rheumatoid arthritis measured by a lectin binding method and its relation to rheumatoid factor","volume":"50","author":"Sumar","year":"1991","journal-title":"Ann Rheum Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/rheumatology\/33.1.36","article-title":"Early agalactosylation of IgG is associated with a more progressive disease course in patients with rheumatoid arthritis: results of a follow-up study","volume":"33","author":"van Zeben","year":"1994","journal-title":"Br J Rheumatol"},{"key":"B36","doi-asserted-by":"crossref","DOI":"10.1002\/elps.11501601133","article-title":"Detection of immunoglobulin G glycosylation changes in patients with rheumatoid arthritis by means of isoelectric focusing and lectin-affinoblotting","volume":"16","author":"Hansler","year":"1995","journal-title":"Electrophoresis"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/elps.1150170321","article-title":"Immunoglobulin G galactosylation deficiency determined by isoelectric focusing and lectin affinoblotting in differential diagnosis of rheumatoid arthritis","volume":"17","author":"Kotz","year":"1996","journal-title":"Electrophoresis"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3164\/jcbn.25.131","article-title":"Abnormal glycosylation of IgG as a clinical parameter in patients with rheumatoid arthritis: its constitutional analysis by HPLC","volume":"25","author":"Mukofujiwara","year":"1998","journal-title":"J Clin Biochem Nutr"},{"key":"B39","article-title":"Characterization of changes in IgG associated oligosaccharide profiles in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis using fluorophore linked carbohydrate electrophoresis","volume":"28","author":"Martin","year":"2001","journal-title":"J Rheumatol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1201\/9781003193616-4","article-title":"Rheumatic disease differentiation using immunoglobulin G sugar printing by high density electrophoresis","volume":"30","author":"Axford","year":"2003","journal-title":"J Rheumatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/art.27533","article-title":"Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis","volume":"62","author":"Ercan","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2018.03.018","article-title":"Low galactosylation of IgG associates with higher risk for future diagnosis of rheumatoid arthritis during 10 years of follow-up","volume":"1864","author":"Gudelj","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13075-018-1540-0","article-title":"Hypogalactosylation of immunoglobulin G in rheumatoid arthritis: relationship to HLA-DRB1 shared epitope, anticitrullinated protein antibodies, rheumatoid factor, and correlation with inflammatory activity","volume":"20","author":"Schwedler","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3906\/biy-2005-7","article-title":"Sex effect on the correlation of immunoglobulin G glycosylation with rheumatoid arthritis disease activity","volume":"44","author":"Ercan","year":"2020","journal-title":"Turk J Biol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/316452a0","article-title":"Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG","volume":"316","author":"Parekh","year":"1985","journal-title":"Nature"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1136\/ard.47.2.91","article-title":"Alterations in carbohydrate composition of serum IgG from patients with rheumatoid arthritis and from pregnant women","volume":"47","author":"Pekelharing","year":"1988","journal-title":"Ann Rheum Dis"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/bf00290198","article-title":"Occurrence of deficient galactosylation of serum IgG prior to the onset of rheumatoid arthritis","volume":"13","author":"Tomana","year":"1994","journal-title":"Rheumatol Int"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310304","article-title":"Abnormal glycosylation of serum IgG from patients with chronic inflammatory diseases","volume":"31","author":"Tomana","year":"1988","journal-title":"Arthritis Rheum-Us"},{"key":"B49","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1046\/j.1365-2249.1996.d01-741.x","article-title":"The relationship between exposed galactose and N-acetylglucosamine residues on IgG in rheumatoid arthritis (RA), juvenile chronic arthritis (JCA) and Sjogren's syndrome (SS)","volume":"105","author":"Bond","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380605","article-title":"Distinct oligosaccharide content of rheumatoid arthritis-derived immune complexes","volume":"38","author":"Bond","year":"1995","journal-title":"Arthritis Rheum"},{"key":"B51","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1006\/jaut.1996.0104","article-title":"A detailed lectin analysis of IgG glycosylation, demonstrating disease specific changes in terminal galactose and N-acetylglucosamine","volume":"10","author":"Bond","year":"1997","journal-title":"J Autoimmun"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/s0009-9120(99)00060-0","article-title":"Fucosylation of IgG heavy chains is increased in rheumatoid arthritis","volume":"32","author":"Gornik","year":"1999","journal-title":"Clin Biochem"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jbchem.a022794","article-title":"Autoantibody activity of IgG rheumatoid factor increases with decreasing levels of galactosylation and sialylation","volume":"128","author":"Matsumoto","year":"2000","journal-title":"J Biochem"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1021\/pr400589m","article-title":"Association between galactosylation of immunoglobulin G and improvement of rheumatoid arthritis during pregnancy is independent of sialylation","volume":"12","author":"Bondt","year":"2013","journal-title":"J Proteome Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-eular.2100","article-title":"Changes of glycosylation of IgG in rheumatoid arthritis patients treated with methotrexate","volume":"61","author":"Gindzienska-Sieskiewicz","year":"2016","journal-title":"Adv Med Sci"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-017-0302-1","article-title":"Characterization of IgG glycosylation in rheumatoid arthritis patients by MALDI-TOF-MS(n) and capillary electrophoresis","volume":"409","author":"Huang","year":"2017","journal-title":"Anal Bioanal Chem"},{"key":"B57","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jchromb.2019.05.027","article-title":"An integrated approach for comprehensive profiling and quantitation of IgG-Fc glycopeptides with application to rheumatoid arthritis","author":"Yau","year":"2019","journal-title":"J Chromatogr B Analyt Technol BioMed Life Sci"},{"key":"B58","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.3390\/ijms21062045","article-title":"Abberant immunoglobulin G glycosylation in rheumatoid arthritis by LTQ-ESI-MS","volume":"21","author":"Su","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B59","doi-asserted-by":"publisher","first-page":"9626","DOI":"10.3390\/ijms26199626","article-title":"Immunoglobulin G subclass-specific glycosylation changes in rheumatoid arthritis","volume":"26","author":"Szabo","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B60","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13075-026-03818-6","article-title":"Immunoglobulin G and plasma glycome in early rheumatoid arthritis differ from matched controls and link less fat-free mass to an accelerated aging phenotype: an exploratory study","volume":"28","author":"Hashmi","year":"2026","journal-title":"Arthritis Res Ther"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3579","article-title":"Regulation of autoantibody activity by the IL-23-T(H)17 axis determines the onset of autoimmune disease","volume":"18","author":"Pfeifle","year":"2017","journal-title":"Nat Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s13020-025-01246-3","article-title":"Serum IgG N-glycans act as serum biomarkers for differentiation of cold and heat pattern in rheumatoid arthritis","volume":"20","author":"Wang","year":"2025","journal-title":"Chin Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12744","article-title":"Sialylation of anti-histone immunoglobulin G autoantibodies determines their capabilities to participate in the clearance of late apoptotic cells","volume":"184","author":"Magorivska","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12987","article-title":"Altered glycan accessibility on native immunoglobulin G complexes in early rheumatoid arthritis and its changes during therapy","volume":"189","author":"Stumer","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1002\/art.27414","article-title":"Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid","volume":"62","author":"Scherer","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/art.39273","article-title":"Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG glycome","volume":"67","author":"Vuckovic","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.eng.2023.01.006","article-title":"Serum igG glycan hallmarks of systemic lupus erythematosus","volume":"26","author":"Pan","year":"2023","journal-title":"Engineering-Prc"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/bf00302151","article-title":"Abnormal galactosylation of serum IgG in patients with systemic lupus erythematosus and members of families with high frequency of autoimmune diseases","volume":"12","author":"Tomana","year":"1992","journal-title":"Rheumatol Int"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1177\/0961203315570686","article-title":"Measuring decreased serum IgG sialylation: a novel clinical biomarker of lupus","volume":"24","author":"Chen","year":"2015","journal-title":"Lupus"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-022-0965-7","article-title":"Control of lupus activity during pregnancy via the engagement of IgG sialylation: novel crosstalk between IgG sialylation and pDC functions","volume":"17","author":"Wang","year":"2023","journal-title":"Front Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1177\/0961203314558861","article-title":"Altered glycosylation of complexed native IgG molecules is associated with disease activity of systemic lupus erythematosus","volume":"24","author":"Sjowall","year":"2015","journal-title":"Lupus"},{"key":"B72","doi-asserted-by":"publisher","first-page":"14178","DOI":"10.1038\/s41598-020-71137-0","article-title":"A novel immunochromatographic strips assay for rapid and simple detection of systemic lupus erythematosus","volume":"10","author":"Sun","year":"2020","journal-title":"Sci Rep"},{"key":"B73","doi-asserted-by":"publisher","first-page":"103883","DOI":"10.1002\/9781119636540.ch25","article-title":"Fucosylation of anti-dsDNA IgG1 correlates with disease activity of treatment-naive systemic lupus erythematosus patients","volume":"77","author":"Han","year":"2022","journal-title":"EBioMedicine"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1177\/1352458516631036","article-title":"Abnormal galactosylation of immunoglobulin G in cerebrospinal fluid of multiple sclerosis patients","volume":"22","author":"Decker","year":"2016","journal-title":"Mult Scler"},{"key":"B75","doi-asserted-by":"publisher","first-page":"104921","DOI":"10.1016\/j.msard.2023.104921","article-title":"Higher MRI lesion load in multiple sclerosis is related to the N-glycosylation changes of cerebrospinal fluid immunoglobulin G","volume":"79","author":"Turcic","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-021-09996-1","article-title":"Aberrant immunoglobulin G glycosylation in multiple sclerosis","volume":"17","author":"Kennedy","year":"2022","journal-title":"J Neuroimmune Pharmacol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1689835","article-title":"CNS-compartmentalized IgG aggregates and glycosylation in multiple sclerosis contribute to oligoclonal bands and neuronal cytotoxicity","volume":"17","author":"Asokan","year":"2026","journal-title":"Front Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3390\/biomedicines8100410","article-title":"Glycosylation alterations in multiple sclerosis show increased proinflammatory potential","volume":"8","author":"Cvetko","year":"2020","journal-title":"Biomedicines"},{"key":"B79","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12974-015-0450-1","article-title":"Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid","volume":"12","author":"Wuhrer","year":"2015","journal-title":"J Neuroinflamm"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13051206","article-title":"Altered igG N-glycosylation at onset of type 1 diabetes in children is predominantly driven by changes in the fab N-glycans","volume":"13","author":"Plavsa","year":"2025","journal-title":"Biomedicines"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-022-05703-8","article-title":"Children at onset of type 1 diabetes show altered N-glycosylation of plasma proteins and IgG","volume":"65","author":"Rudman","year":"2022","journal-title":"Diabetologia"},{"key":"B82","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2337\/dc17-1042","article-title":"N-glycan profile and kidney disease in type 1 diabetes","volume":"41","author":"Bermingham","year":"2018","journal-title":"Diabetes Care"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102503","article-title":"Glycomic analysis of antibody indicates distinctive glycosylation profile in patients with autoimmune cholangitis","volume":"113","author":"Zhou","year":"2020","journal-title":"J Autoimmun"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.669137","article-title":"Changes of serum igG glycosylation patterns in primary biliary cholangitis patients","volume":"12","author":"Zeng","year":"2021","journal-title":"Front Immunol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/s12967-024-05173-z","article-title":"Autoimmune hepatitis displays distinctively high multi-antennary sialylation on plasma N-glycans compared to other liver diseases","volume":"22","author":"Pongracz","year":"2024","journal-title":"J Transl Med"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2021.108825","article-title":"Glycan biomarkers of autoimmunity and bile acid-associated alterations of the human glycome: Primary biliary cirrhosis and primary sclerosing cholangitis-specific glycans","volume":"230","author":"Maverakis","year":"2021","journal-title":"Clin Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/s0016-5085(12)62539-6","article-title":"Lectin-based immunoassay for aberrant IgG glycosylation as the biomarker for Crohn's disease","volume":"19","author":"Shinzaki","year":"2013","journal-title":"Inflammation Bowel Dis"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000372","article-title":"Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome","volume":"21","author":"Trbojevic Akmacic","year":"2015","journal-title":"Inflammation Bowel Dis"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.01.002","article-title":"Glycosylation of immunoglobulin G associates with clinical features of inflammatory bowel diseases","volume":"154","author":"Simurina","year":"2018","journal-title":"Gastroenterology"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01916-8","article-title":"A unique serum IgG glycosylation signature predicts development of Crohn's disease and is associated with pathogenic antibodies to mannose glycan","volume":"25","author":"Gaifem","year":"2024","journal-title":"Nat Immunol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"8473","DOI":"10.3390\/ijms23158473","article-title":"Distinct longitudinal changes in immunoglobulin G N-glycosylation associate with therapy response in chronic inflammatory diseases","volume":"23","author":"Stambuk","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113924","article-title":"IgG antibodies to cyclic citrullinated peptides exhibit profiles specific in terms of IgG subclasses, Fc-glycans and a fab-Peptide sequence","volume":"9","author":"Lundstrom","year":"2014","journal-title":"PloS One"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203565","article-title":"Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis","volume":"74","author":"Rombouts","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202408769","article-title":"Fc proteoforms of ACPA igG discriminate autoimmune responses in plasma and synovial fluid of rheumatoid arthritis patients and associate with disease activity","volume":"12","author":"Blochl","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23105828","article-title":"The role of igG fc region N-glycosylation in the pathomechanism of rheumatoid arthritis","volume":"23","author":"Gyebrovszki","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.089292","article-title":"Reversible changes in serum immunoglobulin galactosylation during the immune response and treatment of inflammatory autoimmune arthritis","volume":"68","author":"Van Beneden","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1002\/elps.201400575","article-title":"Combination of IgG N-glycomics and corresponding transcriptomics data to identify anti-TNF-alpha treatment responders in inflammatory diseases","volume":"36","author":"Varadi","year":"2015","journal-title":"Electrophoresis"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1007\/s10719-006-5409-0","article-title":"Galactosylation of IgG from rheumatoid arthritis (RA) patients--changes during therapy","volume":"23","author":"Pasek","year":"2006","journal-title":"Glycoconj J"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110961","article-title":"Peripheral blood gene expression and IgG glycosylation profiles as markers of tocilizumab treatment in rheumatoid arthritis","volume":"39","author":"Mesko","year":"2012","journal-title":"J Rheumatol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"R193","DOI":"10.1186\/ar2892","article-title":"Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study","volume":"11","author":"van de Geijn","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-212946","article-title":"Acpa igg galactosylation associates with disease activity in pregnant patients with rheumatoid arthritis","volume":"77","author":"Bondt","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2025.100928","article-title":"Comprehensive immunoglobulin G, A, and M glycopeptide profiling for large-scale biomedical research","volume":"24","author":"van Tol","year":"2025","journal-title":"Mol Cell Proteomics"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1257906","article-title":"Association between immunoglobulin G N-glycosylation and lupus nephritis in female patients with systemic lupus erythematosus: a case-control study","volume":"14","author":"Lu","year":"2023","journal-title":"Front Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.7b03729","article-title":"Substrate preference and interplay of fucosyltransferase 8 and N-acetylglucosaminyltransferases","volume":"139","author":"Tseng","year":"2017","journal-title":"J Am Chem Soc"},{"key":"B105","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/s41467-020-14794-z","article-title":"Structural basis for substrate specificity and catalysis of alpha1,6-fucosyltransferase","volume":"11","author":"Garcia-Garcia","year":"2020","journal-title":"Nat Commun"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3390\/cells15050433","article-title":"Glycomic profiles of IgG, C3 and alpha-1-acid glycoprotein (AGP) before and one year after treatment for active lupus nephritis","volume":"15","author":"Nikolopoulos","year":"2026","journal-title":"Cells"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228883","article-title":"Oligoclonal IgG antibodies in multiple sclerosis target patient-specific peptides","volume":"15","author":"Graner","year":"2020","journal-title":"PloS One"},{"key":"B108","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/10408363.2022.2039591","article-title":"Oligoclonal bands: clinical utility and interpretation cues","volume":"59","author":"Carta","year":"2022","journal-title":"Crit Rev Clin Lab Sci"},{"key":"B109","doi-asserted-by":"publisher","first-page":"117298","DOI":"10.1016\/j.cca.2023.117298","article-title":"N-glycosylation of serum proteins in adult type 1 diabetes mellitus exposes further changes compared to children at the disease onset","volume":"543","author":"Nemcic","year":"2023","journal-title":"Clin Chim Acta"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1126\/science.1129594","article-title":"Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation","volume":"313","author":"Kaneko","year":"2006","journal-title":"Science"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1126\/science.1154315","article-title":"Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc","volume":"320","author":"Anthony","year":"2008","journal-title":"Science"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3390\/biom13060954","article-title":"Anti-TNF biologicals enhance the anti-inflammatory properties of IgG N-glycome in Crohn's disease","volume":"13","author":"Hanic","year":"2023","journal-title":"Biomolecules"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.11.041","article-title":"Engineered sialylation of pathogenic antibodies attenuates autoimmune disease","volume":"172","author":"Pagan","year":"2018","journal-title":"Cell"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1418812112","article-title":"Structure of FcgammaRI in complex with Fc reveals the importance of glycan recognition for high-affinity IgG binding","volume":"112","author":"Lu","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143520","article-title":"Multi-angle effector function analysis of human monoclonal IgG glycovariants","volume":"10","author":"Dashivets","year":"2015","journal-title":"PloS One"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m202069200","article-title":"Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity","volume":"277","author":"Shields","year":"2002","journal-title":"J Biol Chem"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.2210\/pdb3sgj\/pdb","article-title":"Unique carbohydrate-carbohydrate interactions are required for high affinity binding between Fc\u03b3RIII and antibodies lacking core fucose","volume":"108","author":"Ferrara","year":"2011","journal-title":"P Natl Acad Sci USA"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00877","article-title":"Decoding the human immunoglobulin G-glycan repertoire reveals a spectrum of Fc-receptor- and complement-mediated-effector activities","volume":"8","author":"Dekkers","year":"2017","journal-title":"Front Immunol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.929895","article-title":"Role of Fc core fucosylation in the effector function of IgG1 antibodies","volume":"13","author":"Golay","year":"2022","journal-title":"Front Immunol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00646","article-title":"Fc-galactosylation of human immunoglobulin gamma isotypes improves C1q binding and enhances complement-dependent cytotoxicity","volume":"8","author":"Peschke","year":"2017","journal-title":"Front Immunol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.crimmu.2020.06.001","article-title":"Impact of IgG1 N-glycosylation on their interaction with Fc gamma receptors","volume":"1","author":"Cambay","year":"2020","journal-title":"Curr Res Immunol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2016.1218586","article-title":"The immunoglobulin G1 N-glycan composition affects binding to each low affinity Fc gamma receptor","volume":"8","author":"Subedi","year":"2016","journal-title":"MAbs"},{"key":"B123","article-title":"Rheumatoid arthritis-associated IgG N-glycan agalactosylation diminishes neutrophilic inflammation by reducing FcgR binding and downstream signaling","volume-title":"Biorxiv","author":"Pumpe","year":"2026"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2505473122","article-title":"Exploring glycoform-dependent dynamic modulations in human immunoglobulin G via computational and experimental approaches","volume":"122","author":"Yanaka","year":"2025","journal-title":"Proc Natl Acad Sci USA"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134949","article-title":"In vitro glycoengineering of IgG1 and its effect on Fc receptor binding and ADCC activity","volume":"10","author":"Thomann","year":"2015","journal-title":"PloS One"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2006.09.005","article-title":"Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality","volume":"44","author":"Scallon","year":"2007","journal-title":"Mol Immunol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2011.06305.x","article-title":"Novel roles for the IgG Fc glycan","volume":"1253","author":"Anthony","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1111\/imr.70021","article-title":"Soluble factors and mechanisms regulated by sialylated IgG signaling","volume":"330","author":"Edwards","year":"2025","journal-title":"Immunol Rev"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00197","article-title":"Differences in anti-inflammatory actions of intravenous immunoglobulin between mice and men: more than meets the eye","volume":"6","author":"Tjon","year":"2015","journal-title":"Front Immunol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.11.027","article-title":"A monosaccharide residue is sufficient to maintain mouse and human IgG subclass activity and directs IgG effector functions to cellular Fc receptors","volume":"13","author":"Kao","year":"2015","journal-title":"Cell Rep"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2018.1551044","article-title":"Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoclonal antibody with homogeneous glycoforms","volume":"11","author":"Wada","year":"2019","journal-title":"MAbs"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2100399","article-title":"Fc galactosylation promotes hexamerization of human IgG1, leading to enhanced classical complement activation","volume":"207","author":"van Osch","year":"2021","journal-title":"J Immunol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2021.1893427","article-title":"Fc galactosylation follows consecutive reaction kinetics and enhances immunoglobulin G hexamerization for complement activation","volume":"13","author":"Wei","year":"2021","journal-title":"MAbs"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.m111.014563","article-title":"Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination","volume":"11","author":"Selman","year":"2012","journal-title":"Mol Cell Proteomics"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc8378","article-title":"Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity","volume":"371","author":"Larsen","year":"2021","journal-title":"Science"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1532145","article-title":"Immunoglobulin G N-glycome as a biomarker of mortality risk in Escherichia coli induced sepsis","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1933960\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:14:59Z","timestamp":1791198899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1933960\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":136,"alternative-id":["10.3389\/fimmu.2026.1933960"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1933960","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"article-number":"1933960"}}